Physician

Gregory Spana, M.D.

According to 2025 Medicare claims, Gregory Spana, M.D. (NPI: 1639314628) practices urology in the Dover, DE market, with the plurality of this provider's patient population coming from Kent, DE. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF DELAWARE P.A. (NPI: 1396730974; TIN: 510115385) and primary practice location at 19904-3492.

Spana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,192 traditional Medicare patients, billed 22,680 HCPCS/CPT codes, and received $606,361 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,060 prescription claims across 592 beneficiaries totaling $1,140,833 in drug costs, led by Xtandi (Enzalutamide). DME data shows 122 claims. Open Payments data shows 32 records totaling $685. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $374,193 to $606,361. Similarly, Part D prescription costs have risen steadily, from $215,092 to $1,140,833. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$328K$655K2015 Medicare payment: $374,193 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $370,920 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $407,299 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $392,618 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $505,163 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $655,328 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $617,236 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $637,830 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $527,926 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $606,361 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201593210,562$374,193
20169718,788$370,920
20171,02510,374$407,299
20181,21010,844$392,618
20191,24613,353$505,163
20201,23519,031$655,328
20211,22115,419$617,236
20221,34015,245$637,830
20231,21012,826$527,926
20241,19222,680$606,361

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$570K$1.1M2015 Drug cost: $215,092 (USD; Tot_Drug_Cst)2016 Drug cost: $283,210 (USD; Tot_Drug_Cst)2017 Drug cost: $220,668 (USD; Tot_Drug_Cst)2018 Drug cost: $233,863 (USD; Tot_Drug_Cst)2019 Drug cost: $320,751 (USD; Tot_Drug_Cst)2020 Drug cost: $471,273 (USD; Tot_Drug_Cst)2021 Drug cost: $381,250 (USD; Tot_Drug_Cst)2022 Drug cost: $464,389 (USD; Tot_Drug_Cst)2023 Drug cost: $792,855 (USD; Tot_Drug_Cst)2024 Drug cost: $1,140,833 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154911,832$215,092
20164891,651$283,210
20174551,611$220,668
20184761,752$233,863
20195061,749$320,751
20204841,798$471,273
20214851,705$381,250
20225971,942$464,389
20235872,056$792,855
20245922,060$1,140,833

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$22K$44K2015 Medicare payment: $28,791 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $23,649 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $27,488 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $23,416 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $33,981 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $44,333 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $42,224 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $42,133 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $41,251 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $34,562 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201516192$28,791
201613233$23,649
201716252$27,488
201812226$23,416
201917297$33,981
202014266$44,333
202113263$42,224
2022N/R296$42,133
2023N/R237$41,251
2024N/R122$34,562

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8291,259$96
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's606807$13
51798Ultrasound measurement of bladder capacity after voiding563739$9
82570Creatinine level to test for kidney function or muscle injury502610$5
81003Automated urinalysis test564720$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide501,500$704,302
OrgovyxRelugolix601,800$159,643
MyrbetriqMirabegron795,490$79,450
TrelstarTriptorelin Pamoate182,880$74,897
GemtesaVibegron342,460$37,149

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4352Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), eachNN/R39$22,521
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R40$11,428
A4332Lubricant, individual sterile packet, eachNN/R30$328
A4357Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, eachNN/R13$285

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$685PROGENICS PHARMACEUTICALS, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gregory Spana, M.D.?

Tedicare shows public-source Medicare data for Gregory Spana, M.D. (NPI 1639314628), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Spana, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregory Spana, M.D.?

Gregory Spana, M.D. is linked to UROLOGY ASSOCIATES OF DELAWARE P.A. (billing NPI 1396730974) in the available physician profile data.

Does Gregory Spana, M.D. have Open Payments data?

Gregory Spana, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.